Pathology & Lab Medicine

Clinicians discuss the rapidly evolving therapies, technology, and surgical approaches for early-stage NSCLC and take a fresh look at the future of care.

NYU lung cancer specialists discuss advances in adjuvant therapy for non–small cell lung cancer, including targeted therapy.

Thoracic specialists discuss surgical interventions for early-stage NSCLC and weigh the value of neoadjuvant therapy in operable and locally advanced disease.

In the final episode, experts at UCSD and La Jolla Institute discuss current clinical trials of a cancer vaccine and future directions for neoantigen vaccines.

A nurse practitioner with NYU's pulmonary intervention team chronicles the NSCLC patient experience from diagnosis to revolutionary treatment modalities.